搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
同花顺股票频道
14 天
贝达药业:RGB-5088胰岛细胞注射液处于临床研究阶段
公司回答表示:公司战略合作伙伴杭州瑞普晨创科技有限公司自主研发的RGB-5088胰岛细胞注射液的临床试验申请已于2024年12月获国家药品监督管理局批准,目前处于临床研究阶段。有关RGB-5088胰岛细胞注射液的临床研究进展情况,您可以关注瑞普晨创官方网站的 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Agrees to policy changes
To resume some flights
Charged with capital murder
Woman drowned her dog
Offers $100 to WI voters
Trump rescinds order
Large-capacity ban upheld
Signs critical mineral order
US agency kills CO wolf
Cuts $580 million in funding
Nearly departs from taxiway
‘Vice Squad’ actor dies
Baseball card sells for $1M+
Brunson files for divorce
NYC jury finds 2 guilty
Awards fighter jet contract
Minnesota senator resigns
Australian tourist killed
UAE to invest $1.4T in US
US Treasury lifts sanctions
UCLA sued over attack
Toronto plane crash report
SBA to cut workforce
68 bridges need assessment
Plans to invest $55B+ in US
RU drones strike UKR city
NY congestion deadline
Scores 888th career goal
Sued over false advertising
Texas measles cases rise
Giants sign Humphrey
1st NCAA Tournament win
US sells rockets to Saudi
反馈